EP3475285 - MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.12.2022 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 07.01.2022 | ||
Former | Grant of patent is intended Status updated on 26.08.2021 | ||
Former | Examination is in progress Status updated on 19.03.2021 | ||
Former | Request for examination was made Status updated on 29.03.2019 | ||
Former | The international publication has been made Status updated on 29.12.2017 | Most recent event Tooltip | 03.05.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 05.06.2024 [2024/23] | Applicant(s) | For all designated states Suzhou Kintor Pharmaceuticals, Inc. 218 Xinghu Street, Research Building C4-401 Suzhou Industrial Park Suzhou Jiangsu 215123 / CN | [2019/18] | Inventor(s) | 01 /
GUO, Chuangxing 4672 Corte Mar Asombrosa San Diego, CA 92130 / US | 02 /
TONG, Youzhi 45-30 251 Street Little Neck, NY 11362 / US | [2019/18] | Representative(s) | Epping - Hermann - Fischer Patentanwaltsgesellschaft mbH Schloßschmidstraße 5 80639 München / DE | [2019/18] | Application number, filing date | 17814538.9 | 17.05.2017 | [2019/18] | WO2017CN84683 | Priority number, date | US201662354754P | 25.06.2016 Original published format: US 201662354754 P | [2019/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017219800 | Date: | 28.12.2017 | Language: | EN | [2017/52] | Type: | A1 Application with search report | No.: | EP3475285 | Date: | 01.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.12.2017 takes the place of the publication of the European patent application. | [2019/18] | Type: | B1 Patent specification | No.: | EP3475285 | Date: | 09.02.2022 | Language: | EN | [2022/06] | Search report(s) | International search report - published on: | CN | 28.12.2017 | (Supplementary) European search report - dispatched on: | EP | 26.11.2019 | Classification | IPC: | C07D487/04, C07D519/00, A61K31/5377, A61P35/00 | [2019/18] | CPC: |
A61P35/00 (EP,KR);
C07D487/04 (EP,KR,US);
A61K31/5377 (KR);
C07D519/00 (EP,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/18] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | MECHANISTISCHES TARGET VON RAPAMYCINSIGNALWEGHEMMERN UND THERAPEUTISCHE ANWENDUNGEN DAVON | [2019/18] | English: | MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF | [2019/18] | French: | CIBLE MÉCANISTE D'INHIBITEURS DE LA VOIE DE SIGNALISATION DE LA RAPAMYCINE ET SES APPLICATIONS THÉRAPEUTIQUES | [2019/18] | Entry into regional phase | 17.01.2019 | National basic fee paid | 17.01.2019 | Search fee paid | 17.01.2019 | Designation fee(s) paid | 17.01.2019 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 17.01.2019 | Examination requested [2019/18] | 15.06.2020 | Amendment by applicant (claims and/or description) | 19.03.2021 | Despatch of a communication from the examining division (Time limit: M04) | 15.07.2021 | Reply to a communication from the examining division | 27.08.2021 | Communication of intention to grant the patent | 21.12.2021 | Fee for grant paid | 21.12.2021 | Fee for publishing/printing paid | 21.12.2021 | Receipt of the translation of the claim(s) | Opposition(s) | 10.11.2022 | No opposition filed within time limit [2023/03] | Fees paid | Renewal fee | 22.05.2019 | Renewal fee patent year 03 | 31.03.2020 | Renewal fee patent year 04 | 27.05.2021 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 17.05.2017 | AL | 09.02.2022 | AT | 09.02.2022 | CY | 09.02.2022 | CZ | 09.02.2022 | DK | 09.02.2022 | EE | 09.02.2022 | ES | 09.02.2022 | FI | 09.02.2022 | HR | 09.02.2022 | IT | 09.02.2022 | LT | 09.02.2022 | LV | 09.02.2022 | MC | 09.02.2022 | MK | 09.02.2022 | NL | 09.02.2022 | PL | 09.02.2022 | RO | 09.02.2022 | RS | 09.02.2022 | SE | 09.02.2022 | SI | 09.02.2022 | SK | 09.02.2022 | SM | 09.02.2022 | BG | 09.05.2022 | NO | 09.05.2022 | GR | 10.05.2022 | IE | 17.05.2022 | LU | 17.05.2022 | BE | 31.05.2022 | CH | 31.05.2022 | LI | 31.05.2022 | IS | 09.06.2022 | PT | 09.06.2022 | [2024/23] |
Former [2024/20] | HU | 17.05.2017 | |
AL | 09.02.2022 | ||
AT | 09.02.2022 | ||
CY | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
IT | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SI | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IE | 17.05.2022 | ||
LU | 17.05.2022 | ||
BE | 31.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2024/18] | HU | 17.05.2017 | |
AL | 09.02.2022 | ||
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
IT | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SI | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IE | 17.05.2022 | ||
LU | 17.05.2022 | ||
BE | 31.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/35] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
IT | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SI | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IE | 17.05.2022 | ||
LU | 17.05.2022 | ||
BE | 31.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/25] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SI | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IE | 17.05.2022 | ||
LU | 17.05.2022 | ||
BE | 31.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/20] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SI | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IE | 17.05.2022 | ||
LU | 17.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/10] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SI | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
LU | 17.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/09] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
LU | 17.05.2022 | ||
CH | 31.05.2022 | ||
LI | 31.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/08] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
LU | 17.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/06] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
MC | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2023/01] | AL | 09.02.2022 | |
AT | 09.02.2022 | ||
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2022/49] | AT | 09.02.2022 | |
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SK | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2022/48] | AT | 09.02.2022 | |
CZ | 09.02.2022 | ||
DK | 09.02.2022 | ||
EE | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2022/47] | AT | 09.02.2022 | |
DK | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RO | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
SM | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2022/46] | AT | 09.02.2022 | |
DK | 09.02.2022 | ||
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2022/42] | AT | 09.02.2022 | |
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
IS | 09.06.2022 | ||
PT | 09.06.2022 | ||
Former [2022/39] | AT | 09.02.2022 | |
ES | 09.02.2022 | ||
FI | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
PT | 09.06.2022 | ||
Former [2022/36] | AT | 09.02.2022 | |
ES | 09.02.2022 | ||
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
LV | 09.02.2022 | ||
NL | 09.02.2022 | ||
PL | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
GR | 10.05.2022 | ||
PT | 09.06.2022 | ||
Former [2022/35] | ES | 09.02.2022 | |
HR | 09.02.2022 | ||
LT | 09.02.2022 | ||
NL | 09.02.2022 | ||
RS | 09.02.2022 | ||
SE | 09.02.2022 | ||
BG | 09.05.2022 | ||
NO | 09.05.2022 | ||
PT | 09.06.2022 | ||
Former [2022/34] | ES | 09.02.2022 | |
LT | 09.02.2022 | ||
NL | 09.02.2022 | ||
NO | 09.05.2022 | ||
PT | 09.06.2022 | ||
Former [2022/33] | LT | 09.02.2022 | |
NO | 09.05.2022 | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [X]CN103450204 (SHANGHAI INST MATERIA MEDICA) [X] 1-42 * the abstract, claims 1-11 *; | [X]CN102675323 (NANJING REMEDIES DRUG RES & DEV CO LTD) [X] 1-42 * the abstract, claims 1-9 *; | [A]CN102558185 (SHANGHAI INST MATERIA MEDICA) [A] 1-42 * the abstract, claims 1-10 * | [X] - DUGAR, S. et al., "Synthesis and evaluation of pyrrolotriazine based molecules as PI3 kinase inhibitors", Bioorganic & Medicinal Chemistry Letters, (20150610), vol. 25, no. 16, pages 3142 - 3146, XP055226049 [X] 1-42 DOI: http://dx.doi.org/10.1016/j.bmcl.2015.06.007 |